On 31 March, at the American College of Cardiology (ACC) Annual Scientific Session & Expo in Chicago, US, the findings from the PURSUIT Phase IIb clinical trial were presented. The study evaluated the ...
In another potential win for patients with early-stage Alzheimer’s disease, Anavex Life Science’s precision medicine blarcasemine has met its primary endpoints in a late-stage trial. Announced at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback